GB0006770D0 - Vaccine composition - Google Patents

Vaccine composition

Info

Publication number
GB0006770D0
GB0006770D0 GBGB0006770.2A GB0006770A GB0006770D0 GB 0006770 D0 GB0006770 D0 GB 0006770D0 GB 0006770 A GB0006770 A GB 0006770A GB 0006770 D0 GB0006770 D0 GB 0006770D0
Authority
GB
United Kingdom
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0006770.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GBGB0006770.2A priority Critical patent/GB0006770D0/en
Publication of GB0006770D0 publication Critical patent/GB0006770D0/en
Priority to GBGB0101094.1A priority patent/GB0101094D0/en
Priority to EP01914018A priority patent/EP1265598B1/en
Priority to DE60121925T priority patent/DE60121925T2/en
Priority to US10/221,954 priority patent/US20050181063A1/en
Priority to AU39407/01A priority patent/AU780182B2/en
Priority to CA002399695A priority patent/CA2399695A1/en
Priority to PCT/GB2001/001248 priority patent/WO2001070200A1/en
Priority to ES01914018T priority patent/ES2272447T3/en
Priority to JP2001568398A priority patent/JP4944335B2/en
Priority to AT01914018T priority patent/ATE334658T1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0006770.2A 2000-03-22 2000-03-22 Vaccine composition Ceased GB0006770D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0006770.2A GB0006770D0 (en) 2000-03-22 2000-03-22 Vaccine composition
GBGB0101094.1A GB0101094D0 (en) 2000-03-22 2001-01-16 Pharmaceutical composition
AT01914018T ATE334658T1 (en) 2000-03-22 2001-03-22 MEDICINAL PRODUCTS FOR ADMINISTRATION TO MUCOUS MEASURES
US10/221,954 US20050181063A1 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for administration to mucosal surfaces
DE60121925T DE60121925T2 (en) 2000-03-22 2001-03-22 MEDICINAL PRODUCT FOR ADMINISTRATION ON MICE
EP01914018A EP1265598B1 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for application to mucosal surfaces
AU39407/01A AU780182B2 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for administration to mucosal surfaces
CA002399695A CA2399695A1 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for administration to mucosal surfaces
PCT/GB2001/001248 WO2001070200A1 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for administration to mucosal surfaces
ES01914018T ES2272447T3 (en) 2000-03-22 2001-03-22 PHARMACEUTICAL COMPOSITION TO APPLY ON MUCOUS SURFACES.
JP2001568398A JP4944335B2 (en) 2000-03-22 2001-03-22 Pharmaceutical composition for administration to the mucosal surface

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0006770.2A GB0006770D0 (en) 2000-03-22 2000-03-22 Vaccine composition

Publications (1)

Publication Number Publication Date
GB0006770D0 true GB0006770D0 (en) 2000-05-10

Family

ID=9888065

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0006770.2A Ceased GB0006770D0 (en) 2000-03-22 2000-03-22 Vaccine composition
GBGB0101094.1A Ceased GB0101094D0 (en) 2000-03-22 2001-01-16 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB0101094.1A Ceased GB0101094D0 (en) 2000-03-22 2001-01-16 Pharmaceutical composition

Country Status (2)

Country Link
JP (1) JP4944335B2 (en)
GB (2) GB0006770D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008139804A1 (en) * 2007-05-14 2008-11-20 Ltt Bio-Pharma Co., Ltd. Low-molecule drug-containing nanoparticle having sustained release negatively charged group

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ337054A (en) * 1997-01-30 2001-03-30 Chiron Corp Microparticles PLA and PLG with adsorbed viral antigen to stimulate immune responses particularly for intracellular viruses such as HSV-1 or HSV-2, varicella zoster virus. epstein-barr virus or cytomegalovirus (CMV)

Also Published As

Publication number Publication date
GB0101094D0 (en) 2001-02-28
JP2003527413A (en) 2003-09-16
JP4944335B2 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
IL227966A0 (en) Vaccine composition
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
GB0103170D0 (en) Vaccine composition
GB0103171D0 (en) Vaccine composition
AU1591402A (en) Vaccine
GB0014288D0 (en) Vaccine
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0025694D0 (en) Vaccine
GB0003082D0 (en) Vaccine
GB0006770D0 (en) Vaccine composition
GB0006693D0 (en) Vaccine
GB0015722D0 (en) Vaccine
GB0015935D0 (en) Vaccine
GB0016686D0 (en) Novel vaccine
GB0025573D0 (en) Vaccine
GB0022991D0 (en) Vaccine
GB0018602D0 (en) Vaccine
GB0025579D0 (en) Vaccine
GB0015747D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)